U.S. flag

An official website of the United States government

NM_000256.3(MYBPC3):c.1024G>A (p.Val342Ile) AND not specified

Germline classification:
Likely benign (1 submission)
Last evaluated:
Aug 10, 2012
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000035365.5

Allele description [Variation Report for NM_000256.3(MYBPC3):c.1024G>A (p.Val342Ile)]

NM_000256.3(MYBPC3):c.1024G>A (p.Val342Ile)

Gene:
MYBPC3:myosin binding protein C3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p11.2
Genomic location:
Preferred name:
NM_000256.3(MYBPC3):c.1024G>A (p.Val342Ile)
HGVS:
  • NC_000011.10:g.47346273C>T
  • NG_007667.1:g.11430G>A
  • NM_000256.3:c.1024G>AMANE SELECT
  • NP_000247.2:p.Val342Ile
  • LRG_386t1:c.1024G>A
  • LRG_386:g.11430G>A
  • LRG_386p1:p.Val342Ile
  • NC_000011.9:g.47367824C>T
  • c.1024G>A
Protein change:
V342I
Links:
dbSNP: rs397515882
NCBI 1000 Genomes Browser:
rs397515882
Molecular consequence:
  • NM_000256.3:c.1024G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000059013Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Likely benign
(Aug 10, 2012)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided31not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000059013.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedclinical testing PubMed (1)

Description

Val342Ile in exon 12 of MYBPC3: This variant is not expected to have clinical si gnificance due to a lack of conservation across species, including several mamma ls and evolutionarily distant species that carry an isoleucine (Ile; this varian t) at this position despite high nearby amino acid conservation. In addition, co mputational analyses (AlignGVGD, PolyPhen2, SIFT) do not suggest a high likeliho od of impact to the protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided3not provided1not provided

Last Updated: Sep 29, 2024